循证护理联合恩替卡韦治疗乙肝肝硬化腹水患者临床疗效分析.docVIP

循证护理联合恩替卡韦治疗乙肝肝硬化腹水患者临床疗效分析 　　【摘要】 目的 探讨循证护理联合恩替卡韦治疗乙型肝炎（乙肝）肝硬化腹水患者的临床疗效。 　　方法 100例乙肝肝硬化腹水患者， 随机分为试验组和对照组， 各50例。两组患者均采用恩替卡韦治疗， 在此基础上试验组患者采取循证护理， 对照组患者采取常规护理。比较两组患者的临床疗效和护理满意度。结果 试验组总有效率为70.0%， 对照组总有效率为50.0%， 试验组总有效率优于对照组， 差异有统计学意义（P0.05）。试验组护理满意度为96.0%， 对照组护理满意度为82.0%， 试验组护理满意度优于对照组， 差异有统计学意义（P0.05）。结论 对恩替卡韦治疗的乙肝肝硬化腹水患者采取循证护理， 可以提高患者的临床效果和护理满意度， 值得在临床推广。 　　【关键词】 循证护理；恩替卡韦；乙型肝炎肝硬化腹水 　　DOI：10.14163/j.cnki.11-5547/r.2017.35.077 　　【Abstract】 Objective To discuss the clinical efficacy of evidence-based nursing combined with entecavir in the treatment of patients with hepatitis B cirrhosis ascites. Methods A total of 100 patients with hepatitis B cirrhosis ascites were randomly divided into experimental group and control group， with 50 cases in each group. Both groups were treated with entecavir， and the experimental group also received evidence-based nursing. The control group received conventional nursing. Comparison were made on clinical efficacy and nursing satisfaction between two groups. Results The experimental group had total effective rate as 70.0%， which was 50.0% in the control group. The experimental group had better total effective rate than the control group， and the difference was statistically significant （P0.05）. The experimental group had nursing satisfaction as 96.0%， which was 82.0% in the control group. The experimental group had better nursing satisfaction than the control group， and the difference was statistically significant （P0.05）. Conclusion For patients treated with entecavir， evidence-based nursing can improve the patient’s clinical effect and nursing satisfaction， and is worthy of clinical promotion. 　　【Key words】 Evidence-based nursing； Entecavir； Hepatitis B cirrhosis ascites 　　乙肝肝硬化是由乙肝引起的肝硬化， 其病理表?F为广泛的肝细胞坏死， 肝硬化腹水是最常见并发症之一。恩替卡韦是核苷类似物， 可以有效的对抗乙肝病毒， 目前广泛的应用于临床治疗， 疗效尚可。相比于药物治疗， 如果护理不当很容易诱发上消化道出血、肝性脑病等并发症[1]。循证护理是一种新兴的护理模式， 主要是以患者为中心， 进行全方面的护理措施。作者从2016年起对乙肝肝硬化腹水患者采取循证护理联合恩替卡韦治疗取得了较好的临床效果， 报告如下。 　　1 资料与方法 　　1. 1 一般资料 选取2016年1月～201